
News|Articles|August 30, 2024
Ecolab Continues Mission to Protect What's Vital With Deep Investment in Life Sciences
Author(s)Ecolab
Ecolab is looking to the future with new opportunities to partner with Pharma for critical solutions to support drug development and manufacturing.
Trending on Pharmaceutical Technology
1
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
2
AAPS PharmSci 360: CMC Strategies, Part 1
3
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5
